CIM
CIM Investment Management Portfolio holdings
AUM
$525M
This Quarter Return
+5.19%
1 Year Return
+18.97%
3 Year Return
+87.66%
5 Year Return
+127.31%
10 Year Return
+233.62%
AUM
$262M
AUM Growth
+$262M
(+8.6%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
4.01%
Top 10 Holdings %
Top 10 Hldgs %
29.06%
Holding
368
New
74
Increased
129
Reduced
121
Closed
23
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.7M |
| 2 |
Eli Lilly
LLY
|
$1.59M |
| 3 |
IBM
IBM
|
$1.25M |
| 4 |
Target
TGT
|
$1.1M |
| 5 |
Abbott
ABT
|
$1.08M |
Top Sells
| 1 |
Simon Property Group
SPG
|
$1.64M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
$1.47M |
| 3 |
PepsiCo
PEP
|
$1.28M |
| 4 |
Johnson & Johnson
JNJ
|
$1.15M |
| 5 |
American Airlines Group
AAL
|
$912K |
Sector Composition
| 1 | Financials | 12.04% |
| 2 | Technology | 11.55% |
| 3 | Healthcare | 10.9% |
| 4 | Industrials | 7.32% |
| 5 | Consumer Discretionary | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$297B
| $1.46M | 0.56% |
34,394
-2,630
| -7% | -$111K |
|
27
DuPont de Nemours
DD
$32.2B
| $1.45M | 0.55% |
28,054
-2,660
| -9% | -$138K |
|
28
Chevron
CVX
$324B
| $1.39M | 0.53% |
13,540
-1,120
| -8% | -$115K |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $1.39M | 0.53% |
13,289
-1,040
| -7% | -$109K |
|
30
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.37M | 0.52% |
9,460
-1,023
| -10% | -$148K |
|
31
Adobe
ADBE
$151B
| $1.33M | 0.51% |
12,207
-930
| -7% | -$101K |
|
32
Mastercard
MA
$538B
| $1.32M | 0.5% |
12,958
-1,020
| -7% | -$104K |
|
33
PayPal
PYPL
$67.1B
| $1.31M | 0.5% |
31,856
-2,450
| -7% | -$100K |
|
34
Home Depot
HD
$405B
| $1.28M | 0.49% |
9,978
-750
| -7% | -$96.5K |
|
35
Merck
MRK
$210B
| $1.28M | 0.49% |
20,550
-1,500
| -7% | -$93.7K |
|
36
Broadcom
AVGO
$1.4T
| $1.26M | 0.48% |
7,296
+2,415
| +49% | +$417K |
|
|
37
IBM
IBM
$227B
| $1.25M | 0.48% |
+7,869
| New | +$1.25M |
|
38
Altria Group
MO
$113B
| $1.2M | 0.46% |
18,974
-1,460
| -7% | -$92.3K |
|
39
AbbVie
ABBV
$372B
| $1.13M | 0.43% |
17,953
-1,250
| -7% | -$78.8K |
|
40
Biogen
BIIB
$19.4B
| $1.13M | 0.43% |
3,608
-260
| -7% | -$81.4K |
|
|
41
Target
TGT
$43.6B
| $1.1M | 0.42% |
+16,038
| New | +$1.1M |
|
42
Gilead Sciences
GILD
$140B
| $1.1M | 0.42% |
13,893
-1,060
| -7% | -$83.9K |
|
43
Charles Schwab Corporation Depositary Shares each representing 1/40th interest in a share of 5.95% Non-Cumulative Perpetual Preferred Stock, Series D
SCHW.PRD
$756M
| $1.09M | 0.42% |
40,000
| – | – |
|
|
44
Abbott
ABT
$231B
| $1.08M | 0.41% |
+25,644
| New | +$1.08M |
|
|
KKR.PRA
45
DELISTED
KKR & Co. Inc. 6.75% Series A Preferred Units
KKR.PRA
| $1.08M | 0.41% |
40,000
| – | – |
|
|
HSEA.CL
46
DELISTED
HSBC Holdings plc
HSEA.CL
| $1.08M | 0.41% |
40,000
| – | – |
|
47
Honeywell
HON
$139B
| $1.08M | 0.41% |
9,235
-720
| -7% | -$84K |
|
|
WFC.PRW
48
DELISTED
Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu
WFC.PRW
| $1.04M | 0.4% |
40,000
| – | – |
|
49
AT&T
T
$209B
| $1.03M | 0.39% |
25,447
-3,890
| -13% | -$158K |
|
|
EQCO.CL
50
DELISTED
Equity Commonwealth
EQCO.CL
| $1.03M | 0.39% |
40,000
| – | – |
|